# Use of Export in Primary Percutaneous Coronary Intervention

Study · id `cardio:ct-nct05510661` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05510661](<https://clinicaltrials.gov/study/NCT05510661>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05510661

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 300 participants.

## Technical summary

Registry record NCT05510661. Randomized; single masking; primary purpose treatment. Start 2024-01-15 (actual); primary completion 2025-09-24 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 300 participants (enrolled count; ClinicalTrials.gov record NCT05510661, source copy `cardio:ctgov-nct05510661-2026-11-17`, retrieved 2026-11-18)
- Started: 2024-01-15 (actual) (ClinicalTrials.gov record NCT05510661, source copy `cardio:ctgov-nct05510661-2026-11-17`, retrieved 2026-11-18)
- Primary completion: 2025-09-24 (actual) (ClinicalTrials.gov record NCT05510661, source copy `cardio:ctgov-nct05510661-2026-11-17`, retrieved 2026-11-18)
- Completion: 2026-04-17 (actual) (ClinicalTrials.gov record NCT05510661, source copy `cardio:ctgov-nct05510661-2026-11-17`, retrieved 2026-11-18)
- Countries: Pakistan (ClinicalTrials.gov record NCT05510661, source copy `cardio:ctgov-nct05510661-2026-11-17`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05510661-2026-11-17`, retrieved 2026-11-18)

## The registry's words

- Brief title: Use of Export in Primary Percutaneous Coronary Intervention
- Acronym: EPISOO
- Condition: ST-segment Elevation Myocardial Infarction (STEMI)
- Condition: Total Occlusion of Coronary Artery
- Condition: Primary Percutaneous Coronary Intervention
- Intervention (Device): Export Catheter
- Intervention (Device): Balloon catheter
- Lead sponsor: National Institute of Cardiovascular Diseases, Pakistan
- Lead sponsor class: OTHER
- Collaborator: Medtronic
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: National Institute of Cardiovascular Diseases, Pakistan (`cardio:org-national-institute-of-cardiovascular-diseases-pakistan`)
- Registry lists this organization as a collaborator: Medtronic (`cardio:medtronic`)

## Provenance

Content hash: 0b303867cd7a2600ccbd7ae352cf83f71ef0a3cc707f6687a4a751b9316550f0
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
